Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
Date:2/4/2008

included $988 million of ICD sales. On a pro forma basis for 2006 -- as though the Company had acquired Guidant on January 1, 2006 -- CRM sales were $2.026 billion, which included $1.473 billion of ICD sales. U.S. CRM sales in 2007 were $1.371 billion, which included $1.053 billion of ICD sales, as compared to U.S. CRM sales of $908 million, which included $696 million of ICD sales. Pro forma U.S. CRM sales were $1.358 billion, which included $1.053 billion of ICD sales. International CRM sales in 2007 were $753 million, which included $489 million of ICD sales, as compared to international CRM sales of $463 million, which included $292 million of ICD sales. Pro forma international CRM sales were $668 million, which included $420 million of ICD sales.

Reported net loss for 2007 was $495 million, or $0.33 per share. Reported results for 2007 included acquisition, divestiture, litigation and restructuring-related charges, and amortization expense (pre-tax) of $1.9 billion, or $1.10 per share, which consisted of:

-- $560 million, primarily non-cash, associated with the write down of

goodwill in connection with business divestitures;

-- $85 million in-process research and development write offs, related

primarily to the Company's acquisition of Remon Medical Technologies,

Inc.;

-- $37 million related to the Company's acquisition of Guidant;

-- $365 million attributable to estimated potential losses associated with

patent litigation involving the Company's Interventional Cardiology

business;

-- $184 million of restructuring charges associated with the Company's

expense and head count reduction initiatives; and

-- $641 million of amortization expense.

Adjusted net income for 2007, excluding these charges and amortization expense, was $1.2 billion, or $0.77 per share.

Reported net loss for 2006 was $3.6 billion, or $2.81 per share. Reported results for 200
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Boston Scientific to Participate in Merrill Lynch Conference
2. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
3. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
4. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
5. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
8. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
9. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar will ... and clinical safety assessment in biosimilars. , Regulatory frameworks ... biosimilar drug development, however the complex nature of biopharmaceuticals ... safety and efficacy extremely challenging. Based on the specific ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
(Date:1/15/2014)... 2014 AudioNotch is the internet's leading ... the treatment of tinnitus. Patients listen to sound therapy ... a period of weeks to months, their tinnitus volume decreases. ... forms: Notched Music and Notched White Noise. Now, AudioNotch is ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Histogen, Inc., ... products of cells grown under simulated embryonic conditions, today ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic products ... , This agreement is an amendment to the ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Commence the Marketing ... Oncology Market, BASKING RIDGE, N.J., March 28 ... Inc. (MBTG) announced today that it has received an,$88,000 ... recently,announced distribution agreement with Ferring, Inc. of Canada. Ferring,Inc. ...
... TVM Capital Joins Investor Syndicate, VIENNA, ... company developing novel antibodies and antibody fragments,based ... today that it,has acquired future royalty obligations ... payment., Modular Antibody Technology was originally ...
... /PRNewswire/ -. Actavis Group, the,international generic pharmaceuticals ... separate approvals from the U.S. Food & ... (SR). Distribution,of the products will commence immediately., ... in,150mg strength, are the generic equivalent of ...
Cached Biology Technology:Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract 2Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract 3Antibody Engineering Company F-Star Buys Back Royalty Obligations 2Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S. 2
(Date:4/18/2014)... that sprout as soon as they,re planted may be good ... more careful. In the wild, a plant whose seeds sprouted ... disaster. More than just an insurance policy against late frosts ... has long-term advantages too: Plants whose seeds put off ... species, finds in a team of researchers working at the ...
(Date:4/17/2014)... , Respiratory syncytial virus (RSV) is a ... life-threating illness in very young and elderly populations. ... enters host cells through the fusion protein RSV ... interfering peptides that prevent bundle formation limit RSV ... susceptible to degradation. In this issue of the ...
(Date:4/17/2014)... Professor Marc Andr Gauthier and Professor Luca Razzari ... each been awarded large grants from the John ... for Innovation (CFI) for the acquisition of state-of-the-art ... be added matching grants from the Ministre de ... et de la Technologie (MESRST). These new laboratories ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6New state-of-the-art biotech and nanotech equipment for INRS 2
... more than a dozen scientists from the U.S. Forest ... universities and Region 5 Ecology Program recently released a ... managers as they revise plans for the national forests ... The three most southern national forests in the Sierra ...
... new study from the University of Colorado Denver shows that ... some graves lavish and ornate while the vast majority were ... burials were so ornate, but what,s striking is that they ... 10,000 years," said Julien Riel-Salvatore, Ph.D., assistant professor of anthropology ...
... , , , , , , ... , , AUDIO: ... , Click here for more information. , ... , , , , ...
Cached Biology News:Science synthesis to help guide land management of nation's forests 2Early human burials varied widely but most were simple 2Early human burials varied widely but most were simple 3Low-pitched song indicates fairy-wren size 2Low-pitched song indicates fairy-wren size 3
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048...
... [HDAC8-48] to HDAC8 Regulation of ... mechanisms such as DNA methylation, ATP-dependent ... of histones, which include the dynamic ... of lysine residues present in the ...
... 2-D Sample Preparation for Membrane Proteins ... process 25 membrane,protein extracts for 2-D gel ... Membrane Protein Extraction Kit , ... pellet,fractions with a packed cell weight of ...
...
Biology Products: